Stem cell therapy for tennis elbow (lateral epicondylitis). MSC treatments repair damaged elbow tendons, relieve pain, and restore arm function without surgery.
Stem cell therapy for tennis elbow (lateral epicondylitis) at StemCell Longevita in Istanbul repairs the damaged extensor tendon origin, resolving chronic elbow pain and restoring grip strength without surgery.
Tennis elbow involves chronic degeneration of the common extensor tendon at the lateral epicondyle. MSCs repair the damaged tendon tissue by promoting collagen synthesis, resolving chronic inflammation, and regenerating the tendon-bone junction (enthesis). This addresses the structural damage rather than temporarily masking pain.
Patients with chronic lateral epicondylitis (>3 months duration), failed conservative treatment including physical therapy and corticosteroid injections, and those wishing to avoid surgical tendon debridement. Both athletes and non-athletes with repetitive strain injuries benefit.
After clinical evaluation and elbow imaging, treatment involves IV MSC infusion combined with ultrasound-guided injection into the lateral epicondyle region. Precise delivery to the damaged tendon origin is essential for optimal results.
Pain reduction within 2-3 weeks, improved grip strength within 1-2 months, full recovery typically within 3-4 months. Follow-up ultrasound shows tendon healing and reduced inflammation. Recurrence rates are lower than with steroid injections.
Precise ultrasound-guided MSC delivery by experienced sports medicine specialists at 60-80% lower cost than Western surgical alternatives.
Tennis elbow stem cell therapy from €5,500, including orthopedic assessment, guided injection, hotel, transfers, and follow-up.
Related treatments: Osteoarthritis Stem Cell Therapy | Spinal Osteoarthritis Stem Cell Therapy | Bone Fracture Stem Cell Therapy | Bursitis Stem Cell Therapy | Facet Syndrome Stem Cell Therapy